Is Spravato (esketamine) a controlled substance?
Medically reviewed by Drugs.com. Last updated on Aug 6, 2020.
Yes. Spravato (esketamine) is a Schedule III Controlled Substance in the United States.
Spravato is rapid acting nasal spray used conjunction with an oral antidepressant, for use in adults with treatment-resistant depression.
Spravato is also used with an oral antidepressant to treat depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions.
Spravato contains esketamine, which is the s-enantiomer of ketamine. Ketamine is a mixture of two enantiomers (mirror image molecules). The FDA first approved ketamine (Ketalar) in 1970 for use as a rapid-acting general anesthetic, but in more recent times has become known as a drug of abuse (Special K) due to its hallucinogenic properties.
Both esketamine and ketamine are listed under schedule III of the Controlled Substances Act (CSA).
Related Medical Questions
- SSRI’s vs SNRI’s - What's the difference between them?
- How long does Xanax last for / stay in your system?
- Klonopin vs Xanax - How are they different?
- What is the difference between Celexa and Lexapro?
- Lorazepam vs Xanax: What is the difference?
- Lexapro vs Zoloft: How do they compare?
- Prozac vs Zoloft - What are the Differences & Similarities?
- Vraylar vs Abilify - How do they compare?
- Shall I take Trintellix (vortioxetine) in the night or morning?
- Does vitamin D help with depression?
- Does CBD Oil help with anxiety or depression?
- Is Trintellix the same as Brintellix?
- How does Abilify MyCite work?
- What does depression feel like?
- How is Zulresso administered for the treatment of Postpartum Depression?